BeiGene Patent Battle: Uncertainty In The Oncology Market (NASDAQ:BGNE)
Zeferli Introduction BeiGene (NASDAQ:BGNE) is a pioneering global biotech company, committed to advancing innovative and affordable oncology treatments. With three ...
Zeferli Introduction BeiGene (NASDAQ:BGNE) is a pioneering global biotech company, committed to advancing innovative and affordable oncology treatments. With three ...
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said ...
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing ...
During the last week of March the prominent European Patent Office (EPO) issued its annual Patent Index of 2022. Since ...
Sony (NYSE:) Interactive Entertainment, the video game goliath running the PlayStation brand, filed a patent for a framework allowing ...
Zebra Applied sciences (NASDAQ:ZBRA) disclosed Thursday it agreed to pay $360M to Honeywell (NASDAQ:HON) for previous damages as a part ...
Ambassadors talk about earlier than the opening ceremony of the twelfth Ministerial Convention on the headquarters of the World Commerce ...
Patents search to commerce off the advantages to the inventor of exclusivity with the social advantages of disclosure to the ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.